Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Characteristics of cytosine deaminase-5-fluorocytosine system. Enhancement of radiation cytotoxicity and bystander effect.

Szary J, Missol E, Szala S.

Adv Exp Med Biol. 1998;451:121-3. No abstract available.

PMID:
10026860
2.

Cytotoxic effects of 5-fluorocytosine on melanoma cells transduced with cytosine deaminase gene.

Lü H, Wu D, Wan Y, Gu B, Wang J.

J Environ Pathol Toxicol Oncol. 2000;19(1-2):9-12.

PMID:
10905502
3.
4.
5.
6.

Cytosine deaminase gene as a positive selection marker.

Wei K, Huber BE.

J Biol Chem. 1996 Feb 16;271(7):3812-6.

7.

Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit.

Yin L, Fu S, Wang X, Nanakorn T, Won J, Deisseroth A.

Chin Med J (Engl). 2001 Sep;114(9):972-5.

PMID:
11780394
8.

Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.

Pierrefite-Carle V, Baqué P, Gavelli A, Mala M, Chazal M, Gugenheim J, Bourgeon A, Milano G, Staccini P, Rossi B.

J Natl Cancer Inst. 1999 Dec 1;91(23):2014-9.

PMID:
10580026
9.

Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.

Kievit E, Nyati MK, Ng E, Stegman LD, Parsels J, Ross BD, Rehemtulla A, Lawrence TS.

Cancer Res. 2000 Dec 1;60(23):6649-55.

10.
11.
12.

In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.

Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards CA.

Cancer Res. 1993 Oct 1;53(19):4619-26.

PMID:
8402637
13.

Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.

Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, Deisseroth AB.

Blood. 1998 Jul 15;92(2):672-82.

15.

Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.

Hanna NN, Mauceri HJ, Wayne JD, Hallahan DE, Kufe DW, Weichselbaum RR.

Cancer Res. 1997 Oct 1;57(19):4205-9.

16.
17.

Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine.

Ge K, Xu L, Zheng Z, Xu D, Sun L, Liu X.

Int J Cancer. 1997 May 16;71(4):675-9.

18.

Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.

Fox ME, Lemmon MJ, Mauchline ML, Davis TO, Giaccia AJ, Minton NP, Brown JM.

Gene Ther. 1996 Feb;3(2):173-8. Erratum in: Gene Ther 1996 Aug;3(8):741.

PMID:
8867865
19.

The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.

Nyati MK, Symon Z, Kievit E, Dornfeld KJ, Rynkiewicz SD, Ross BD, Rehemtulla A, Lawrence TS.

Gene Ther. 2002 Jul;9(13):844-9.

20.

Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene.

Hlavatý J, Hlubinová K, Altaner C.

Neoplasma. 1999;46(5):267-76.

PMID:
10665841

Supplemental Content

Support Center